Natalie C. Holles's most recent trade in Day One Biopharmaceuticals Inc was a trade of 22,500 Stock Option (right to buy Common Stock) done . Disclosure was reported to the exchange on June 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Day One Biopharmaceuticals... | Natalie C. Holles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 22,500 | 22,500 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharmaceuticals... | Natalie C. Holles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 15,000 | 15,000 | - | - | Deferred Restricted Stock Unit (RSU) | |
| Third Harmonic Bio Inc | Natalie C. Holles | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 400,000 | 400,000 | - | - | Employee Stock Option (right to buy) | |
| Third Harmonic Bio Inc | Natalie C. Holles | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 50,000 | 50,000 | - | - | Restricted Stock Unit | |
| Day One Biopharmaceuticals... | Natalie C. Holles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 32,335 | 32,335 | - | - | Stock Option (right to buy Common Stock) | |
| Third Harmonic Bio Inc | Natalie C. Holles | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2024 | 20,222 | 433,854 | - | - | Employee Stock Option (right to buy) | |
| Third Harmonic Bio Inc | Natalie C. Holles | Director, CEO | Sale of securities on an exchange or to another person at price $ 12.18 per share. | 09 May 2024 | 20,222 | 1,218,836 | - | 12.2 | 246,300 | Common Stock |
| Third Harmonic Bio Inc | Natalie C. Holles | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.20 per share. | 09 May 2024 | 20,222 | 1,239,058 | - | 4.2 | 84,932 | Common Stock |
| Third Harmonic Bio Inc | Natalie C. Holles | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.20 per share. | 11 Apr 2024 | 13,558 | 1,232,394 | - | 4.2 | 56,944 | Common Stock |
| Third Harmonic Bio Inc | Natalie C. Holles | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2024 | 13,558 | 454,076 | - | - | Employee Stock Option (right to buy) | |
| Third Harmonic Bio Inc | Natalie C. Holles | Director, CEO | Sale of securities on an exchange or to another person at price $ 12.19 per share. | 11 Apr 2024 | 13,558 | 1,218,836 | - | 12.2 | 165,214 | Common Stock |
| Third Harmonic Bio Inc | Natalie Holles C. | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 396,000 | 396,000 | - | - | Employee Option Grant (right to buy) | |
| Third Harmonic Bio Inc | C. Holles Natalie | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 396,000 | 396,000 | - | - | Employee Option Grant (right to buy) | |
| Day One Biopharmaceuticals... | Natalie C. Holles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 37,500 | 37,500 | - | - | Director Stock Option (Right to buy Common Stock) | |
| Third Harmonic Bio Inc | Natalie C. Holles | Director, CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Mar 2023 | 467,634 | 0 | - | - | Employee Stock Option (right to buy) | |
| Third Harmonic Bio Inc | Natalie C. Holles | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 467,634 | 467,634 | - | - | Employee Stock Option (right to buy) | |
| Third Harmonic Bio Inc | Natalie C. Holles | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 360,000 | 360,000 | - | - | Employee Stock Option (right to buy) | |
| Third Harmonic Bio Inc | Natalie C. Holles | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 205,000 | 205,000 | - | - | Employee Stock Option (right to buy) | |
| Third Harmonic Bio Inc | Natalie C. Holles | Director, CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Mar 2023 | 205,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Third Harmonic Bio Inc | Natalie C. Holles | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2022 | 205,000 | 205,000 | - | - | Employee Option Grant (right to buy) | |
| Day One Biopharmaceuticals... | Natalie C. Holles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 28,700 | 28,700 | - | - | Director Stock Option (Right to buy Common Stock) | |
| Allakos Inc | Natalie C. Holles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 7,700 | 7,700 | - | - | Stock Option (Right to buy) | |
| Allakos Inc | Natalie C. Holles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 4,000 | 4,000 | - | - | Stock Option (Right to buy) |